PPARG and metabolic syndrome: For example, PPARα agonists (fibrates), PPARγ agonists (thiazolidinediones -TZDs) and combined PPARα/γ agonists (glitazars) are therapeutic agents for CVD prevention, T2DM and dyslipidemia.